In the BioHarmony Drug Report Database

"Preview" Icon

Eletriptan

Relpax (eletriptan) is a small molecule pharmaceutical. Eletriptan was first approved as Relpax on 2002-12-26. It is used to treat migraine disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1B, 5-hydroxytryptamine receptor 1F, and 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1E and 5-hydroxytryptamine receptor 1A.

 

Trade Name

 

Relpax
 

Common Name

 

eletriptan
 

ChEMBL ID

 

CHEMBL1510
 

Indication

 

migraine disorders
 

Drug Class

 

Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

Image (chem structure or protein)

Eletriptan structure rendering